ReviewPharmaceuticals (Basel, Switzerland)2024

Targeting Microglia in Neuroinflammation: H3 Receptor Antagonists as a Novel Therapeutic Approach for Alzheimer's Disease, Parkinson's Disease, and Autism Spectrum Disorder.

Shilu Deepa Thomas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.